Targeted Drugs With Companion Dx May Draw Medicare NCD Interest – Phurrough
Executive Summary
Targeted drugs indicated for use with companion diagnostics raise the kind of reimbursement concerns that may make them eligible topics for a Medicare national coverage determination, Steve Phurrough, former director of the Centers for Medicare and Medicaid Services coverage and analysis group, suggests.